Polycythemia vera and pregnancy:: A case report with the use of hydroxyurea in the first trimester

被引:11
|
作者
Pata, O
Tok, CE
Yazici, G
Pata, C
Öz, AU
Aban, M
Dilek, S
机构
[1] Univ Mersin, Fac Med, Dept Obstet & Gynecol, Mersin, Turkey
[2] Univ Mersin, Fac Med, Dept Internal Med, Mersin, Turkey
关键词
polycythemia vera; pregnancy; hydroxyurea; teratogeny;
D O I
10.1055/s-2004-823773
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycythemia vera (PV) is rarely associated with pregnancy. A 34-year-old patient treated with hydroxyurea for PV became pregnant and was referred to our clinic. At the patient's request, pregnancy was continued. The patient's hematocrit level remained below 45% without any treatment throughout her pregnancy, and a healthy male infant (without any congenital malformations or complications) was delivered at 37 weeks. This case report suggests that normal pregnancy and delivery is possible in patients with PV.
引用
收藏
页码:135 / 137
页数:3
相关论文
共 50 条
  • [31] Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance
    Venugopal, Sangeetha
    Mascarenhas, John
    [J]. LANCET HAEMATOLOGY, 2022, 9 (07): : E462 - E463
  • [32] Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report
    Regensburger, Jasmin
    Rauchegger, Teresa
    Loacker, Lorin
    Falkner, Florian
    Feistritzer, Clemens
    Teuchner, Barbara
    [J]. BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [33] Hydroxyurea for Treatment of Nephrotic Syndrome Associated With Polycythemia Vera
    Hundemer, Gregory L.
    Rosales, Ivy A.
    Chen, Yi-Bin
    Colvin, Robert B.
    Tolkoff-Rubin, Nina E.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (03) : 465 - 468
  • [34] LYMPHOMA TRANSFORMATION IN POLYCYTHEMIA-VERA TREATED WITH HYDROXYUREA
    HAWKINS, TE
    CARTER, JM
    ROMERIL, KR
    JACKSON, SR
    GREEN, GJ
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (04) : 290 - 290
  • [35] Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia
    Dingli D.
    Tefferi A.
    [J]. Current Hematologic Malignancy Reports, 2006, 1 (2) : 69 - 74
  • [36] Novel Agents in the Treatment of Polycythemia Vera Beyond Hydroxyurea
    Yacoub, Abdulraheem
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S14 - S16
  • [37] Leg ulcer in a patient treated with hydroxyurea for polycythemia vera
    Hanchi, Imen
    Zeglaoui, Faten
    Ezzine, Nedia
    Daoud, Linda
    Karoui, Mongi
    Fazaa, Becima
    Kamoun, Mohamed Ridha
    [J]. PRESSE MEDICALE, 2006, 35 (7-8): : 1174 - 1176
  • [38] HYDROXYUREA, AN EFFECTIVE AGENT FOR THE TREATMENT OF POLYCYTHEMIA-VERA
    DONOVAN, PB
    BERK, PD
    GOLDBERG, JD
    DRESCH, C
    KNOSPE, WH
    LASZLO, J
    NAJEAN, Y
    PETERSON, P
    SILBERSTEIN, EB
    TATARSKY, I
    PENG, JW
    KAPLAN, ME
    [J]. CLINICAL RESEARCH, 1982, 30 (02): : A315 - A315
  • [39] Hydroxyurea induced oscillations in twelve patients with polycythemia vera
    Tauscher, Jan
    Siegel, Fabian
    Petrides, Petro E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1227 - 1229
  • [40] Hydroxyurea-induced longitudinal melanonychia in polycythemia vera
    de Sousa, Susana Marques
    Marques, Marta Rafael
    [J]. GALICIA CLINICA, 2021, 82 (01): : 58 - 58